Kinnate Biopharma Inc.
INHIBITORS OF RAF KINASES

Last updated:

Abstract:

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Status:
Application
Type:

Utility

Filling date:

25 Mar 2021

Issue date:

30 Sep 2021